Skip to content

Clinical trials

Phase 3 Stomach Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 3 Country / region: Japan Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20025
20031
20041
20053
20062
20071
20082
20092
20101
20112
20133
20144
20162
20173
20184
20201
20213
20223
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Active, not recruiting6
Terminated4
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Japan Clinical Oncology Group5
Taiho Pharmaceutical Co., Ltd.4
Amgen3
AstraZeneca3
Merck Sharp & Dohme LLC3
Ono Pharmaceutical Co., Ltd.3
Wakayama Medical University3
Astellas Pharma Global Development, Inc.2
Daiichi Sankyo2
Haruhiko Fukuda2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms53
Adenocarcinoma5
Neoplasms4
Esophageal Neoplasms2
Neoplasm Metastasis2
Digestive System Neoplasms1
Gastrointestinal Diseases1
Gastrointestinal Neoplasms1
Stomach Diseases1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.